Lv21
101 积分 2021-03-25 加入
Achieving an Objective Response Following Two Cycles of Neoadjuvant Chemotherapy Plus Anti-PD-(L)1 Inhibitors Might Predict the Optimal Pathological Response in Resectable Stage II-III Nonsmall Cell Lung Cancer
10小时前
求助中
Neoadjuvant chemo-immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography scan predict complete pathological response?
10小时前
求助中
Prognostic Implications of Lymph Node Status in Non–Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study
10小时前
已完结
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non–small cell lung cancer
10小时前
已完结
Machine learning algorithms integrating positron emission tomography/computed tomography features to predict pathological complete response after neoadjuvant chemoimmunotherapy in lung cancer
11小时前
已完结
Prognostic Implications of Lymph Node Status in Non–Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study
11小时前
已完结
Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA–N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center
11小时前
已完结
Current practice of pathologic response assessment following chemoimmunotherapy for non‐small cell lung cancer (NSCLC) in Germany: first real‐world data from the multicentre Re‐GraDE study
11小时前
已完结
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival
11小时前
已完结
Clinical and Genetic Characteristics of Early-onset Lung Adenocarcinoma in a Large Chinese Cohort
5天前
已完结
皖公网安备34019202002308
